Community

Richard Snyder, Ph.D.

Vice President, Science and Technology, Viral Vector Services Pharma Services, Thermo Fisher Scientific

Dr. Snyder was the founder of Florida Biologix, which was spun out
of the University of Florida in 2015 and merged to create Brammer
Bio in 2016. Dr. Snyder has been investigating virus biology, vector
development, cGMP manufacturing and analytical technologies,
and viral vector–mediated gene transfer for over 32 years. Dr. Snyder
received his doctoral degree in microbiology from the State University
of New York at Stony Brook and obtained his BA in biology from
Washington University in St. Louis.

Contributions

Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems

Accelerating The Development of Viral Vector Manufacturing Processes

Digital Droplet PCR for Viral Vector Analysis

Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing

Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing

Investing for Successful Advancement of Viral Vector Manufacturing